Wu K - Search Results

1

GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.

Yue X, Zhao P, Wu K, Huang J, Zhang W, Wu Y, Liang X, He X. Yue X, et al. Among authors: wu y, wu k. Tumour Biol. 2016 Jul;37(7):9789-96. doi: 10.1007/s13277-016-4877-5. Epub 2016 Jan 25. Tumour Biol. 2016. PMID: 26810068

2

Emerging roles of Nrf2 signal in non-small cell lung cancer.

Tian Y, Liu Q, He X, Yuan X, Chen Y, Chu Q, Wu K. Tian Y, et al. Among authors: wu k. J Hematol Oncol. 2016 Feb 27;9:14. doi: 10.1186/s13045-016-0246-5. J Hematol Oncol. 2016. PMID: 26922479 Free PMC article. Review.

3

Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis.

Xu HX, Wu KJ, Tian YJ, Liu Q, Han N, He XL, Yuan X, Wu GS, Wu KM. Xu HX, et al. Medicine (Baltimore). 2016 Jul;95(27):e4085. doi: 10.1097/MD.0000000000004085. Medicine (Baltimore). 2016. PMID: 27399099 Free PMC article. Review.

4

Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.

Liu Q, Yu S, Li A, Xu H, Han X, Wu K. Liu Q, et al. Among authors: wu k. Tumour Biol. 2017 Jun;39(6):1010428317712445. doi: 10.1177/1010428317712445. Tumour Biol. 2017. PMID: 28639898 Free article. Review.

5

CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.

Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, Chen R, Liu X, Xu H, Cai S, Chen H, Li W, Xu S, Wang L, Hu Z, Zhuang Q, Wang L, Wu K, Liu J, Ye Z, Ji JY, Wang C, Chen K. Wang T, et al. Among authors: wu l, wu k. Oncotarget. 2014 Nov 15;5(21):10293-306. doi: 10.18632/oncotarget.2511. Oncotarget. 2014. PMID: 25296973 Free PMC article.

6

DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.

Han N, Yuan X, Wu H, Xu H, Chu Q, Guo M, Yu S, Chen Y, Wu K. Han N, et al. Among authors: wu h, wu k. Oncotarget. 2015 Mar 20;6(8):5877-88. doi: 10.18632/oncotarget.3463. Oncotarget. 2015. PMID: 25788272 Free PMC article.

7

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis.

Yuan X, Wu H, Xu H, Han N, Chu Q, Yu S, Chen Y, Wu K. Yuan X, et al. Among authors: wu h, wu k. Sci Rep. 2015 May 21;5:10338. doi: 10.1038/srep10338. Sci Rep. 2015. PMID: 25996086 Free PMC article.

8

The DACH/EYA/SIX gene network and its role in tumor initiation and progression.

Liu Y, Han N, Zhou S, Zhou R, Yuan X, Xu H, Zhang C, Yin T, Wu K. Liu Y, et al. Among authors: wu k. Int J Cancer. 2016 Mar 1;138(5):1067-75. doi: 10.1002/ijc.29560. Epub 2015 Jun 12. Int J Cancer. 2016. PMID: 26096807 Review.

9

Notch signaling: an emerging therapeutic target for cancer treatment.

Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S, Wu GS, Wu K. Yuan X, et al. Among authors: wu h, wu gs, wu k. Cancer Lett. 2015 Dec 1;369(1):20-7. doi: 10.1016/j.canlet.2015.07.048. Epub 2015 Sep 1. Cancer Lett. 2015. PMID: 26341688 Free article. Review.

10

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.

Xu H, Wu K, Tian Y, Liu Q, Han N, Yuan X, Zhang L, Wu GS, Wu K. Xu H, et al. Among authors: wu gs, wu k. Int J Oncol. 2016 Oct;49(4):1343-50. doi: 10.3892/ijo.2016.3639. Epub 2016 Jul 29. Int J Oncol. 2016. PMID: 27499099 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,406 results

Search Page

Filters